Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
167 studies found for:    pediatric medulloblastoma
Show Display Options
Rank Status Study
1 Recruiting Social Cognition and Brain Integrity in Survivors of Pediatric Medulloblastoma
Condition: Medulloblastoma
Intervention:
2 Withdrawn A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma
Conditions: Medulloblastoma, Childhood;   Rhabdomyosarcoma
Intervention: Drug: LY2940680
3 Completed GDC-0449 in Treating Young Patients With Medulloblastoma That is Recurrent or Did Not Respond to Previous Treatment
Condition: Recurrent Childhood Medulloblastoma
Interventions: Drug: vismodegib;   Other: laboratory biomarker analysis;   Other: pharmacological study
4 Completed
Has Results
Vismodegib in Treating Younger Patients With Recurrent or Refractory Medulloblastoma
Condition: Recurrent Childhood Medulloblastoma
Interventions: Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Vismodegib
5 Completed Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
Condition: Untreated Childhood Medulloblastoma
Interventions: Drug: Cisplatin;   Radiation: Craniospinal Irradiation;   Drug: Cyclophosphamide;   Radiation: Involved-Field Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Drug: Lomustine;   Other: Quality-of-Life Assessment;   Radiation: Radiation Therapy;   Drug: Vincristine Sulfate
6 Not yet recruiting Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
Condition: Untreated Childhood Medulloblastoma
Interventions: Drug: Cisplatin;   Drug: Cyclophosphamide;   Other: Laboratory Biomarker Analysis;   Drug: Lomustine;   Radiation: Radiation Therapy;   Drug: Vincristine Sulfate
7 Active, not recruiting Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-Metastatic Desmoplastic Medulloblastoma
Condition: Untreated Childhood Medulloblastoma
Interventions: Drug: Vincristine Sulfate;   Drug: Cyclophosphamide;   Drug: Methotrexate;   Drug: Etoposide;   Drug: Carboplatin;   Other: Laboratory Biomarker Analysis;   Other: Cognitive Assessment
8 Active, not recruiting Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System
Conditions: Untreated Childhood Medulloblastoma;   Untreated Childhood Pineoblastoma;   Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Cyclophosphamide;   Drug: Etoposide Phosphate;   Drug: Isotretinoin;   Other: Laboratory Biomarker Analysis;   Procedure: Peripheral Blood Stem Cell Transplantation;   Drug: Thiotepa;   Drug: Vincristine Sulfate;   Drug: Vorinostat
9 Completed Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
Conditions: Untreated Childhood Medulloblastoma;   Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
Interventions: Drug: etoposide;   Drug: cyclophosphamide;   Drug: cisplatin;   Biological: filgrastim;   Drug: carboplatin;   Drug: thiotepa;   Drug: methotrexate;   Drug: leucovorin calcium;   Drug: vincristine sulfate;   Procedure: autologous hematopoietic stem cell transplantation;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
10 Completed Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor
Conditions: Untreated Childhood Medulloblastoma;   Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
Interventions: Drug: cisplatin;   Drug: cyclophosphamide;   Drug: vincristine sulfate;   Drug: etoposide;   Procedure: therapeutic conventional surgery;   Radiation: 3-dimensional conformal radiation therapy
11 Completed Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
Conditions: Brain Tumors;   Central Nervous System Tumors
Interventions: Biological: filgrastim;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: lomustine;   Drug: mesna;   Drug: vincristine sulfate;   Radiation: low-LET electron therapy;   Radiation: low-LET photon therapy
12 Completed Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
Conditions: Brain Tumors;   Central Nervous System Tumors
Interventions: Biological: filgrastim;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: vincristine sulfate;   Radiation: radiation therapy
13 Unknown  Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cisplatin;   Drug: lomustine;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Radiation: radiation therapy
14 Unknown  Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cisplatin;   Drug: lomustine;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Radiation: radiation therapy
15 Active, not recruiting Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
Conditions: Recurrent Childhood Medulloblastoma;   Recurrent Childhood Pineoblastoma;   Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified
Interventions: Biological: Bevacizumab;   Drug: Irinotecan Hydrochloride;   Drug: Temozolomide
16 Recruiting Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma
Conditions: Untreated Childhood Medulloblastoma;   Untreated Childhood Pineoblastoma;   Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
Interventions: Radiation: Radiation Therapy;   Drug: Vincristine Sulfate;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Cyclophosphamide;   Biological: Filgrastim;   Drug: Isotretinoin;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
17 Completed Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors
Conditions: Brain Tumors;   Central Nervous System Tumors
Interventions: Genetic: DNA ploidy analysis;   Genetic: comparative genomic hybridization;   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization
18 Active, not recruiting Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cisplatin;   Drug: lomustine;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Radiation: iodine I 131 monoclonal antibody 3F8;   Radiation: radiation therapy
19 Completed Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: thiotepa;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
20 Completed Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: filgrastim;   Drug: amifostine trihydrate;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: vincristine sulfate;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.